499 related articles for article (PubMed ID: 16309383)
21. An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium.
Newby DE; Wright RA; Ludlam CA; Fox KA; Boon NA; Webb DJ
Thromb Haemost; 1997 Oct; 78(4):1242-8. PubMed ID: 9364992
[TBL] [Abstract][Full Text] [Related]
22. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
23. Acute effects of different alcoholic beverages on vascular endothelium, inflammatory markers and thrombosis fibrinolysis system.
Tousoulis D; Ntarladimas I; Antoniades C; Vasiliadou C; Tentolouris C; Papageorgiou N; Latsios G; Stefanadis C
Clin Nutr; 2008 Aug; 27(4):594-600. PubMed ID: 18295937
[TBL] [Abstract][Full Text] [Related]
24. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.
Liu L; Zhao SP; Zhou HN; Li QZ; Li JX
J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915
[TBL] [Abstract][Full Text] [Related]
25. Local and systemic effects of intra-arterial desmopressin in healthy volunteers and patients with type 3 von Willebrand disease. Role of interleukin-6.
Newby DE; Stewart A; Witherow FN; Grieve S; Dawson P; Fox KA; Webb DJ; Ludlam CA
Thromb Haemost; 2000 Aug; 84(2):195-203. PubMed ID: 10959689
[TBL] [Abstract][Full Text] [Related]
26. Acute systemic inflammation enhances endothelium-dependent tissue plasminogen activator release in men.
Chia S; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2003 Jan; 41(2):333-9. PubMed ID: 12535831
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient.
Fichtlscherer S; Breuer S; Zeiher AM
Circulation; 2004 Oct; 110(14):1926-32. PubMed ID: 15451794
[TBL] [Abstract][Full Text] [Related]
28. The effect of disease activity related cytokines on the fibrinolytic potential and cICAM-1 expression in rheumatoid arthritis.
Kamper EF; Kopeikina LT; Trontzas P; Potamianou A; Tsiroglou E; Stavridis JC
J Rheumatol; 2000 Nov; 27(11):2545-50. PubMed ID: 11093432
[TBL] [Abstract][Full Text] [Related]
29. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
Orbe J; Chordá C; Montes R; Páramo JA
Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
[TBL] [Abstract][Full Text] [Related]
30. Influence of oral contraceptive use on endothelial t-PA release in healthy premenopausal women.
Hoetzer GL; Stauffer BL; Greiner JJ; Casas Y; Smith DT; DeSouza CA
Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E90-5. PubMed ID: 12388132
[TBL] [Abstract][Full Text] [Related]
31. The fibrinolytic system in chronic renal failure.
Lottermoser K; Petras S; Pöge U; Fimmers R; Hertfelder HJ; Schiermeyer B; Vetter H; Düsing R
Eur J Med Res; 2001 Sep; 6(9):372-6. PubMed ID: 11591527
[TBL] [Abstract][Full Text] [Related]
32. TNF-alpha induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-gamma agonist pioglitazone.
Martens FM; Rabelink TJ; op 't Roodt J; de Koning EJ; Visseren FL
Eur Heart J; 2006 Jul; 27(13):1605-9. PubMed ID: 16762982
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease.
Fichtlscherer S; Breuer S; Heeschen C; Dimmeler S; Zeiher AM
J Am Coll Cardiol; 2004 Jul; 44(1):44-9. PubMed ID: 15234404
[TBL] [Abstract][Full Text] [Related]
34. The effect of different doses of fluvastatin on inflammatory markers in the early phase of acute coronary syndrome.
Yang J; Li XP; Zhao SP; Li J; Li JD; Xie XM
Clin Chim Acta; 2006 Jun; 368(1-2):183-7. PubMed ID: 16472797
[TBL] [Abstract][Full Text] [Related]
35. Bradykinin receptor antagonism and endothelial tissue plasminogen activator release in humans.
Witherow FN; Dawson P; Ludlam CA; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1667-70. PubMed ID: 12869356
[TBL] [Abstract][Full Text] [Related]
36. The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels.
Asselbergs FW; Williams SM; Hebert PR; Coffey CS; Hillege HL; Navis G; Vaughan DE; van Gilst WH; Moore JH
Thromb Haemost; 2006 Oct; 96(4):471-7. PubMed ID: 17003924
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
38. Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation.
Katsaros KM; Kastl SP; Huber K; Zorn G; Maurer G; Glogar D; Wojta J; Christ G; Speidl WS
Thromb Res; 2008; 123(1):79-84. PubMed ID: 18558425
[TBL] [Abstract][Full Text] [Related]
39. Intravascular tumor necrosis factor alpha blockade reverses endothelial dysfunction in rheumatoid arthritis.
Cardillo C; Schinzari F; Mores N; Mettimano M; Melina D; Zoli A; Ferraccioli G
Clin Pharmacol Ther; 2006 Sep; 80(3):275-81. PubMed ID: 16952494
[TBL] [Abstract][Full Text] [Related]
40. Independent relation of vital exhaustion and inflammation to fibrinolysis in apparently healthy subjects.
von Känel R; Frey K; Fischer J
Scand Cardiovasc J; 2004 Mar; 38(1):28-32. PubMed ID: 15204244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]